Channel Therapeutics Statistics

Total Valuation

CHRO has a market cap or net worth of $100.88 million. The enterprise value is $103.12 million.

Market Cap	100.88M
Enterprise Value	103.12M

Important Dates

The next estimated earnings date is Thursday, November 13, 2025, after market close.

Earnings Date	Nov 13, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+81.07%
Shares Change (QoQ)	+4.52%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	2.60M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	-15.53
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-11.41
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.11

Current Ratio	0.11
Quick Ratio	0.01
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-17.91

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-326.06%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	137.63%
Revenue Per Employee	n/a
Profits Per Employee	-$1.13M
Employee Count	11
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +46,775.00% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+46,775.00%
50-Day Moving Average	0.02
200-Day Moving Average	0.02
Relative Strength Index (RSI)	45.16
Average Volume (20 Days)	759,448

Short Selling Information

The latest short interest is 76,911, so 11.66% of the outstanding shares have been sold short.

Short Interest	76,911
Short Previous Month	175,073
Short % of Shares Out	11.66%
Short % of Float	37.06%
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-8.94M
Pretax Income	-9.04M
Net Income	-9.04M
EBITDA	n/a
EBIT	-8.94M
Earnings Per Share (EPS)	-$14.84

Full Income Statement

Balance Sheet

The company has $59,172 in cash and $2.30 million in debt, giving a net cash position of -$2.25 million.

Cash & Cash Equivalents	59,172
Total Debt	2.30M
Net Cash	-2.25M
Net Cash Per Share	n/a
Equity (Book Value)	-6.49M
Book Value Per Share	-9.65
Working Capital	-6.49M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-1.93M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CHRO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-81.07%
Shareholder Yield	-81.07%
Earnings Yield	-8.96%
FCF Yield	n/a

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-6.92%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1